Pharmacotherapy for Dissociative Disorders: A Systematic Review
May 28, 2020 DOI: 10.64239/pi-qt1501 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Randomized |
|---|---|
| Key findings | Across 117 reviewed studies, no medication, including naltrexone, has shown specific benefit for dissociative disorders or symptoms in a randomized trial. The authors note that antipsychotic trials were notably absent from the reviewed evidence. |
Abstract
Reviewing 117 studies, no medication has been shown in a randomized trial to have specific benefit in treating dissociative disorders or dissociative symptoms. That includes naltrexone. Trials of antipsychotics were notably absent in this review.